Patents by Inventor Pritha AGARWALLA

Pritha AGARWALLA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enhanced viral transduction of mammalian cells using material scaffolds
    Patent number: 12649932
    Abstract: Disclosed are compositions and methods for a low cost, tunable, macroporous, alginate scaffold that transduces T cells with vectors under static condition.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: June 9, 2026
    Assignees: North Carolina State University, The University of North Carolina at Chapel Hill
    Inventors: Yevgeny Brudno, Pritha Agarwalla, Gianpietro Dotti
  • IMPLANTABLE SCAFFOLDS AND METHODS OF USE
    Publication number: 20260124135
    Abstract: The present disclosure provides compositions, systems, and methods related to cellular transduction. In particular, the present disclosure provides compositions, systems, and methods pertaining to implantable macroporous scaffolds that facilitate rapid and highly efficient cellular transduction.
    Type: Application
    Filed: October 13, 2023
    Publication date: May 7, 2026
    Inventors: Yevgeny Brudno, Madelyn VanBlunk, Sharda Pandit, Pritha Agarwalla, Gianpietro Dotti
  • ENHANCED VIRAL TRANSDUCTION OF MAMMALIAN CELLS USING MATERIAL SCAFFOLDS
    Publication number: 20230136350
    Abstract: Disclosed are compositions and methods for a low cost, tunable, macroporous, alginate scaffold that transduces T cells with vectors under static condition.
    Type: Application
    Filed: April 12, 2021
    Publication date: May 4, 2023
    Inventors: Yevgeny Brudno, Pritha Agarwalla, Gianpietro Dotti
  • IN SITU RECRUITMENT, REPROGRAMMING, AND RELEASE OF CAR-T CELLS
    Publication number: 20220354972
    Abstract: Disclosed are hydrogel matrixes for use in recruitment and reprogramming of CAR T cells, CAR NK cells, CAR NK T cells, CAR macrophage, Tumor infiltrating NK cells, tumor infiltrating lymphocytes, and marrow infiltrating lymphocytes.
    Type: Application
    Filed: June 18, 2020
    Publication date: November 10, 2022
    Inventors: Yevgeny BRUDNO, Gianpietro DOTTI, Pritha AGARWALLA